Xiaoqian Lin
Research Subjects
Xiaoqian Lin has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Kucernak
Department of Chemistry, Imperial College London, 80 Wood Lane, W12 7TA London, United Kingdom
2 shared publications - Gong-Hao He
Department of Clinical Pharmacy, Clinical College of the 920th Hospital, Kunming Medical University, Kunming, China
2 shared publications - Jennifer Carlson Aske
Translational Oncology Laboratory, Avera Cancer Institute, Sioux Falls, SD 57108, USA
2 shared publications - Liang Xiao
BGI research, Shenzhen, China
2 shared publications - Nandini Dey
Translational Oncology Laboratory, Avera Cancer Institute, Sioux Falls, SD 57108, USA
2 shared publications - Nischal Koirala
Department of Chemical and Biomedical Engineering, Cleveland State University, Cleveland, OH 44115, USA
2 shared publications
Latest Publications
- Open Access
- 30 May 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1379500
Genomic and functional diversity of the human-derived isolates of Faecalibacterium
Introduction: Faecalibacterium is one of the most abundant bacteria in the gut microbiota of healthy adults, highly regarded as a next-generation probiotic. However, the functions of Faecalibacterium genomes from cultured strains and the distribution of different species in populations may differ among different sources.Methods: We here performed an extensive analysis of pan-genomes, functions, and safety evaluation of 136 Faecalibacterium genomes collected from 10 countries.Results: The genomes are clustered into 11 clusters, with only five of them were characterized and validly nomenclated. Over 80% of the accessory genes and unique genes of Faecalibacterium are found with unknown function, which reflects the importance of expanding the collection of Faecalibacterium strains. All the genomes have the potential to produce acetic acid and butyric acid. Nine clusters of Faecalibacterium are found significantly enriched in the healthy individuals compared with patients with type II diabetes..Discussion: This study provides a comprehensive view of genomic characteristic and functions and of culturable Faecalibacterium bacterium from human gut, and enables clinical advances in the future.
- 30 May 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1379500
Open AccessGenomic and functional diversity of the human-derived isolates of Faecalibacterium
Introduction: Faecalibacterium is one of the most abundant bacteria in the gut microbiota of healthy adults, highly regarded as a next-generation probiotic. However, the functions of Faecalibacterium genomes from cultured strains and the distribution of different species in populations may differ among different sources.Methods: We here performed an extensive analysis of pan-genomes, functions, and safety evaluation of 136 Faecalibacterium genomes collected from 10 countries.Results: The genomes are clustered into 11 clusters, with only five of them were characterized and validly nomenclated. Over 80% of the accessory genes and unique genes of Faecalibacterium are found with unknown function, which reflects the importance of expanding the collection of Faecalibacterium strains. All the genomes have the potential to produce acetic acid and butyric acid. Nine clusters of Faecalibacterium are found significantly enriched in the healthy individuals compared with patients with type II diabetes..Discussion: This study provides a comprehensive view of genomic characteristic and functions and of culturable Faecalibacterium bacterium from human gut, and enables clinical advances in the future.
- Open Access
- 28 August 2023
- Published by Wiley in Carbon Energy
- Vol. 6 (1)
Single‐atom Pt on carbon nanotubes for selective electrocatalysis
Utilizing supported single atoms as catalysts presents an opportunity to reduce the usage of critical raw materials such as platinum, which are essential for electrochemical reactions such as hydrogen oxidation reaction (HOR). Herein, we describe the synthesis of a Pt single electrocatalyst inside single‐walled carbon nanotubes (SWCNTs) via a redox reaction. Characterizations via electron microscopy, X‐ray photoelectron microscopy, and X‐ray absorption spectroscopy show the single‐atom nature of the Pt. The electrochemical behavior of the sample to hydrogen and oxygen was investigated using the advanced floating electrode technique, which minimizes mass transport limitations and gives a thorough insight into the activity of the electrocatalyst. The single‐atom samples showed higher HOR activity than state‐of‐the‐art 30% Pt/C while almost no oxygen reduction reaction activity in the proton exchange membrane fuel cell operating range. The selective activity toward HOR arose as the main fingerprint of the catalyst confinement in the SWCNTs.
- 28 August 2023
- Published by Wiley in Carbon Energy
- Vol. 6 (1)
Open AccessSingle‐atom Pt on carbon nanotubes for selective electrocatalysis
Utilizing supported single atoms as catalysts presents an opportunity to reduce the usage of critical raw materials such as platinum, which are essential for electrochemical reactions such as hydrogen oxidation reaction (HOR). Herein, we describe the synthesis of a Pt single electrocatalyst inside single‐walled carbon nanotubes (SWCNTs) via a redox reaction. Characterizations via electron microscopy, X‐ray photoelectron microscopy, and X‐ray absorption spectroscopy show the single‐atom nature of the Pt. The electrochemical behavior of the sample to hydrogen and oxygen was investigated using the advanced floating electrode technique, which minimizes mass transport limitations and gives a thorough insight into the activity of the electrocatalyst. The single‐atom samples showed higher HOR activity than state‐of‐the‐art 30% Pt/C while almost no oxygen reduction reaction activity in the proton exchange membrane fuel cell operating range. The selective activity toward HOR arose as the main fingerprint of the catalyst confinement in the SWCNTs.
- Open Access
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 1775
Abstract 1775: Scope of cell cycle inhibition in HER2+ breast cancer
Background: Proliferative signaling of the HER2- and ER-pathways converge and propagate via cyclin D and CDK4/6, leading to uncontrolled cell cycle progression and resistance to anti- HER2- and ER-targeted therapies. Purpose: We hypothesize that co-targeting HER2 and CDK4/6 will counter the uncontrolled cell cycle progression, initiate cell cycle arrest, and induce apoptosis in Rb-proficient HER2-amplified breast cancer (BC) cells. Methods: HER2+ BC cell lines (Rb-WT): BT474 (HR-positive), SKBR3 (HR-negative), and MDA-MB453 (HR-negative, PIK3CA mutated [H1047R]) were used for the study. We tested real-time proliferation, 3D-ON TOP colony formation, cell cycle inhibition, changes in mitochondrial membrane potential, and apoptosis following drug treatment as a single-agent (Ribociclib [R]/Trastuzumab [T]) or combination (R+T). Basal-level mRNA transcripts for CDK4 and CCND1 and changes in Ki67 following treatment were quantified with RT-qPCR. Cyclin D expression was evaluated in HER2+ tissue microarrays (TMA) by immunohistochemistry. The mechanistic evaluation of the critical downstream signaling nodes was performed by Western blot. Results: Basal-level mRNA transcript expression for CDK4 and CCND1 were substantially higher (relative to GAPDH) in BT474 and MDA-MB453 whereas, moderate-low expression was obtained in SKBR3. Ki67 transcriptional level was attenuated with R, and further attenuation was observed with dual agent treatment except for SKBR3, where a similar trend was conserved but of reduced intensity. Immunohistochemistry showed substantial cyclin D expression in HER2+ TMA signifying opportunities for CDK4/6 inhibitors. BT474 and MDA-MB453 had similar anti-proliferative responses to the combinatorial treatment, whereas SKBR3 showed resistance to growth inhibition. Similar to real-time proliferation, 3D-ON TOP colony formation showed a reduction in proliferative activities with the combination. The cytostatic response was primarily induced by R and did not differ significantly from the combination of treatment. BT474 and MDA-MB453 had >90% G1 phase arrest, while SKBR3 had >70% G1 phase arrest. Changes in the mitochondrial membrane potential and apoptosis were pronounced with the combination in BT474 and MDA-MB453, whereas SKBR3 did not show any significant response. Western blot showed a reduction in Rb phosphorylation (pRb Ser 780 & Ser 807/811) in all cell lines with R treatment, and further attenuation was observed with combinatorial treatment. Changes in the phospho-Akt were more evident with T and R+T combination in BT474 and MDA-MB453 over HER2-amplified/HR-negative SKBR3 cells. Conclusions: The R+T combination counteracted the proliferative signaling in the HR-positive conditions and sensitized neoplastic cells to elicit an enhanced anti-tumorigenic response irrespective of PIK3CA hotspot mutation. Citation Format: Nischal Koirala, Jennifer Aske, Xiaoqian Lin, Nandini Dey, Pradip De. Scope of cell cycle inhibition in HER2+ breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1775.
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 1775
Open AccessAbstract 1775: Scope of cell cycle inhibition in HER2+ breast cancer
Background: Proliferative signaling of the HER2- and ER-pathways converge and propagate via cyclin D and CDK4/6, leading to uncontrolled cell cycle progression and resistance to anti- HER2- and ER-targeted therapies. Purpose: We hypothesize that co-targeting HER2 and CDK4/6 will counter the uncontrolled cell cycle progression, initiate cell cycle arrest, and induce apoptosis in Rb-proficient HER2-amplified breast cancer (BC) cells. Methods: HER2+ BC cell lines (Rb-WT): BT474 (HR-positive), SKBR3 (HR-negative), and MDA-MB453 (HR-negative, PIK3CA mutated [H1047R]) were used for the study. We tested real-time proliferation, 3D-ON TOP colony formation, cell cycle inhibition, changes in mitochondrial membrane potential, and apoptosis following drug treatment as a single-agent (Ribociclib [R]/Trastuzumab [T]) or combination (R+T). Basal-level mRNA transcripts for CDK4 and CCND1 and changes in Ki67 following treatment were quantified with RT-qPCR. Cyclin D expression was evaluated in HER2+ tissue microarrays (TMA) by immunohistochemistry. The mechanistic evaluation of the critical downstream signaling nodes was performed by Western blot. Results: Basal-level mRNA transcript expression for CDK4 and CCND1 were substantially higher (relative to GAPDH) in BT474 and MDA-MB453 whereas, moderate-low expression was obtained in SKBR3. Ki67 transcriptional level was attenuated with R, and further attenuation was observed with dual agent treatment except for SKBR3, where a similar trend was conserved but of reduced intensity. Immunohistochemistry showed substantial cyclin D expression in HER2+ TMA signifying opportunities for CDK4/6 inhibitors. BT474 and MDA-MB453 had similar anti-proliferative responses to the combinatorial treatment, whereas SKBR3 showed resistance to growth inhibition. Similar to real-time proliferation, 3D-ON TOP colony formation showed a reduction in proliferative activities with the combination. The cytostatic response was primarily induced by R and did not differ significantly from the combination of treatment. BT474 and MDA-MB453 had >90% G1 phase arrest, while SKBR3 had >70% G1 phase arrest. Changes in the mitochondrial membrane potential and apoptosis were pronounced with the combination in BT474 and MDA-MB453, whereas SKBR3 did not show any significant response. Western blot showed a reduction in Rb phosphorylation (pRb Ser 780 & Ser 807/811) in all cell lines with R treatment, and further attenuation was observed with combinatorial treatment. Changes in the phospho-Akt were more evident with T and R+T combination in BT474 and MDA-MB453 over HER2-amplified/HR-negative SKBR3 cells. Conclusions: The R+T combination counteracted the proliferative signaling in the HR-positive conditions and sensitized neoplastic cells to elicit an enhanced anti-tumorigenic response irrespective of PIK3CA hotspot mutation. Citation Format: Nischal Koirala, Jennifer Aske, Xiaoqian Lin, Nandini Dey, Pradip De. Scope of cell cycle inhibition in HER2+ breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1775.
- Open Access
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 269
Abstract 269: PD-L1 dominated tumor-CAF-immune cell crosstalk of stromal microenvironment: Endometrial tumor vs. tumor-adjacent normal
Background: In endometrial cancers (EC), the mechanistic contribution of PD-L1/L2 and PD-1 signaling of host’s stromal microenvironment (SME) [cancer-associated fibroblast (CAF) and immune cells] in relation to the tumor (T) cells is elusive. Aim: To understand the tumor-stroma-immune crosstalk in EC, we studied the compartmental pattern of PD-L1, PD-L2, and PD-1 expression in EC tissues and their matched CAFs from both T and tumor-adjacent normal (N) tissues. Method: Over 116 surgically resected T and N tissues were obtained from consented patients with EC at the Avera Cancer Institute (March ‘16 and September ’21). IHC expression was performed in T, N-epithelium, SME (mesenchyme) in the T and N tissues. The staining intensity and distribution pattern were evaluated by a pathologist using a standard scoring system (1% cut-off value). Since fibroblasts are the most abundant cells of SME, the PD-L1 was parallelly evaluated in the multiple passages of cultured T and N derived CAFs by the qRT-PCR, flow-cytometry, and ICC. Result: The expression of 3 immune checkpoint proteins in the epithelial and mesenchyme of N was limited to only rare and focal positivity for PD-L1. The epithelial compartments of the T tissue, in contrast, had 70% positivity for PD-L1, which was independent of differentiation status, presence of TILs, or lymphovascular invasion. PD-L1 positivity was 90% of the SME of tested samples, identified predominantly in the (1) immune component, including macrophages and lymphocytes, and (2) EpCAM-/SMA+/FAP+/S100A4+ CAFs. Both PD-L1 and PD-L2 were identified by flow, ICC, and qRT-PCR in NCAF and TCAF. The overall expression of PD-L2 was found to be qualitatively and quantitatively lesser than that of PD-L1, primarily contributed by SME/stromal macrophages and lymphocytes. PD-1 expression was restricted to the SME/stromal immune components, predominantly lymphocytes. The expression for PD-L1 and PD-L2 mRNA was higher in TCAF than NCAF in successive passages, which ICC and flow cytometry confirmed. Summary: The expression of immune checkpoint proteins, PD-L1, and PD-L2, are primarily tumor-driven and associated with the endometrioid (invasive) and serous adenocarcinomas of grades II and above with myometrial invasion. The expression of PD-L1 and PD-L2 are distributed in both tumor and SME/stromal components, while PD-1 expression is exclusively SME/stromal. Citation Format: Xiaoqian Lin, Jennifer Aske, Adam Dale, Nischal Koirala, Ethan Thompson, Mary Fagerness, Natasha Flier, Paige Davies, Stacy Kehoe, Cheryl Ageton, Kris Gaster, Luis Rojas Espaillat, David Starks, Raed Sulaiman, Pradip De, Nandini Dey. PD-L1 dominated tumor-CAF-immune cell crosstalk of stromal microenvironment: Endometrial tumor vs. tumor-adjacent normal [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 269.
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 269
Open AccessAbstract 269: PD-L1 dominated tumor-CAF-immune cell crosstalk of stromal microenvironment: Endometrial tumor vs. tumor-adjacent normal
Background: In endometrial cancers (EC), the mechanistic contribution of PD-L1/L2 and PD-1 signaling of host’s stromal microenvironment (SME) [cancer-associated fibroblast (CAF) and immune cells] in relation to the tumor (T) cells is elusive. Aim: To understand the tumor-stroma-immune crosstalk in EC, we studied the compartmental pattern of PD-L1, PD-L2, and PD-1 expression in EC tissues and their matched CAFs from both T and tumor-adjacent normal (N) tissues. Method: Over 116 surgically resected T and N tissues were obtained from consented patients with EC at the Avera Cancer Institute (March ‘16 and September ’21). IHC expression was performed in T, N-epithelium, SME (mesenchyme) in the T and N tissues. The staining intensity and distribution pattern were evaluated by a pathologist using a standard scoring system (1% cut-off value). Since fibroblasts are the most abundant cells of SME, the PD-L1 was parallelly evaluated in the multiple passages of cultured T and N derived CAFs by the qRT-PCR, flow-cytometry, and ICC. Result: The expression of 3 immune checkpoint proteins in the epithelial and mesenchyme of N was limited to only rare and focal positivity for PD-L1. The epithelial compartments of the T tissue, in contrast, had 70% positivity for PD-L1, which was independent of differentiation status, presence of TILs, or lymphovascular invasion. PD-L1 positivity was 90% of the SME of tested samples, identified predominantly in the (1) immune component, including macrophages and lymphocytes, and (2) EpCAM-/SMA+/FAP+/S100A4+ CAFs. Both PD-L1 and PD-L2 were identified by flow, ICC, and qRT-PCR in NCAF and TCAF. The overall expression of PD-L2 was found to be qualitatively and quantitatively lesser than that of PD-L1, primarily contributed by SME/stromal macrophages and lymphocytes. PD-1 expression was restricted to the SME/stromal immune components, predominantly lymphocytes. The expression for PD-L1 and PD-L2 mRNA was higher in TCAF than NCAF in successive passages, which ICC and flow cytometry confirmed. Summary: The expression of immune checkpoint proteins, PD-L1, and PD-L2, are primarily tumor-driven and associated with the endometrioid (invasive) and serous adenocarcinomas of grades II and above with myometrial invasion. The expression of PD-L1 and PD-L2 are distributed in both tumor and SME/stromal components, while PD-1 expression is exclusively SME/stromal. Citation Format: Xiaoqian Lin, Jennifer Aske, Adam Dale, Nischal Koirala, Ethan Thompson, Mary Fagerness, Natasha Flier, Paige Davies, Stacy Kehoe, Cheryl Ageton, Kris Gaster, Luis Rojas Espaillat, David Starks, Raed Sulaiman, Pradip De, Nandini Dey. PD-L1 dominated tumor-CAF-immune cell crosstalk of stromal microenvironment: Endometrial tumor vs. tumor-adjacent normal [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 269.
- Open Access
- 22 February 2021
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 12
Taxonomic Description and Genome Sequence of Christensenella intestinihominis sp. nov., a Novel Cholesterol-Lowering Bacterium Isolated From Human Gut
A Gram-staining-negative, non-spore-forming, short, straight rod, non-motile, and obligate anaerobic bacterial strain, AF73-05CM02T, was isolated from a fecal sample of a 30 years old healthy male living in Shenzhen, China. Colonies were approximately 0.2 mm in diameter, beige, and circular after 4 days of incubation on PYG agar under anaerobic conditions at 37°C. Strain AF73-05CM02T grew in a temperature range between 30 and 42°C and a pH range from 6.0 to 8.5, with optimum growth at 37–42°C and pH 7.0. 16S rRNA gene sequence analysis demonstrated that strain AF73-05CM02T belongs to the genus Christensenella and showed the highest level of sequence similarity (98.68%) with Christensenella minuta DSM 22607T. The predominant fatty acids of strain AF73-05CM02T were C10:0 (7.5%), iso-C11:0 (5.6%), C12:0 (7.2%), C14:0 (46.6%), iso-C15:0 (7.4%), C16:0 (9.7%), and C18:1 ω9c (6.9%). Acetic acid, formic acid, butyric acid, and lactic acid were the end products of glucose fermentation. The strain was negative for catalase, indole production, and hydrolysis of gelatin. Genomic relatedness analyses based on average nucleotide identity (ANI) indicated that strain AF73-05CM02T significantly differed from other species of the genus Christensenella, showing ANI values less than 82.89% with the phylogenetically closest species. The G + C content of the genomic DNA was 52.07 mol% from the genome sequence, which differs from that of Christensenella minuta. Several physiological, biochemical, and genotypic properties differentiated the novel bacterial strain from the related species, indicating that the strain represents a new species of the genus Christensenella for which the name Christensenella intestinihominis sp. nov. is proposed, with strain AF73-05CM02T ( = CGMCC 1.5207T = DSM 103477T ) being the type strain. The following study explored the cholesterol-lowering function of strains AF73-05CM02T and Christensenella minuta DSM 22067T and revealed that the two strains exhibit the capacity for removing cholesterol with efficiency rates of 36.6 and 54.3% and produce exopolysaccharide of 234 and 271 mg/L, respectively.
- 22 February 2021
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 12
Open AccessTaxonomic Description and Genome Sequence of Christensenella intestinihominis sp. nov., a Novel Cholesterol-Lowering Bacterium Isolated From Human Gut
A Gram-staining-negative, non-spore-forming, short, straight rod, non-motile, and obligate anaerobic bacterial strain, AF73-05CM02T, was isolated from a fecal sample of a 30 years old healthy male living in Shenzhen, China. Colonies were approximately 0.2 mm in diameter, beige, and circular after 4 days of incubation on PYG agar under anaerobic conditions at 37°C. Strain AF73-05CM02T grew in a temperature range between 30 and 42°C and a pH range from 6.0 to 8.5, with optimum growth at 37–42°C and pH 7.0. 16S rRNA gene sequence analysis demonstrated that strain AF73-05CM02T belongs to the genus Christensenella and showed the highest level of sequence similarity (98.68%) with Christensenella minuta DSM 22607T. The predominant fatty acids of strain AF73-05CM02T were C10:0 (7.5%), iso-C11:0 (5.6%), C12:0 (7.2%), C14:0 (46.6%), iso-C15:0 (7.4%), C16:0 (9.7%), and C18:1 ω9c (6.9%). Acetic acid, formic acid, butyric acid, and lactic acid were the end products of glucose fermentation. The strain was negative for catalase, indole production, and hydrolysis of gelatin. Genomic relatedness analyses based on average nucleotide identity (ANI) indicated that strain AF73-05CM02T significantly differed from other species of the genus Christensenella, showing ANI values less than 82.89% with the phylogenetically closest species. The G + C content of the genomic DNA was 52.07 mol% from the genome sequence, which differs from that of Christensenella minuta. Several physiological, biochemical, and genotypic properties differentiated the novel bacterial strain from the related species, indicating that the strain represents a new species of the genus Christensenella for which the name Christensenella intestinihominis sp. nov. is proposed, with strain AF73-05CM02T ( = CGMCC 1.5207T = DSM 103477T ) being the type strain. The following study explored the cholesterol-lowering function of strains AF73-05CM02T and Christensenella minuta DSM 22067T and revealed that the two strains exhibit the capacity for removing cholesterol with efficiency rates of 36.6 and 54.3% and produce exopolysaccharide of 234 and 271 mg/L, respectively.
- 28 September 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (42) , 47467-47481
Electrocatalyst Performance at the Gas/Electrolyte Interface under High-Mass-Transport Conditions: Optimization of the “Floating Electrode” Method
The thin-film rotating disk electrode (TF-RDE) is a well-developed, conventional ex-situ electrochemical method which is limited by poor mass transport in the dissolved phase and hence can only measure the kinetic response for Pt-based catalysts in a narrow overpotential range. Thus, the applicability of TF-RDE results in assessing how catalysts perform in fuel cells has been questioned. To address this problem, we use the floating electrode (FE) technique which can facilitate high mass transport to a catalyst layer composed of an ultra-low loading of catalyst (1-15 μgPt cmgeo-2) at the gas/electrolyte interface. In this paper, the aspects which have critical effects on the performance of the FE system are measured and parameterised. We find that in order to obtain reproducible results with high performance the following factors need to be taken into account: system cleanliness, break-in procedure, hydrophobic agent, ionomer type and the measurements of catalyst surface area and loading. For some of these parameters, we examined a range of different approaches/materials and determined the optimum configuration. We find that the gas permeability of the hydrophobic agent is an important factor for improving the hydrogen oxidation reaction (HOR) and oxygen reduction reaction (ORR) performance. We provide evidence that the suppression of the HOR and ORR introduced by the Nafion ionomers is more than a local mass transport barrier but that a mechanism involving the adsorption of the sulfonate on Pt also plays a significant role. The work provides intriguing insights into how to manufacture and optimize electrocatalyst systems which must function at the gas/electrolyte interface.
- 28 September 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (42) , 47467-47481
Electrocatalyst Performance at the Gas/Electrolyte Interface under High-Mass-Transport Conditions: Optimization of the “Floating Electrode” Method
The thin-film rotating disk electrode (TF-RDE) is a well-developed, conventional ex-situ electrochemical method which is limited by poor mass transport in the dissolved phase and hence can only measure the kinetic response for Pt-based catalysts in a narrow overpotential range. Thus, the applicability of TF-RDE results in assessing how catalysts perform in fuel cells has been questioned. To address this problem, we use the floating electrode (FE) technique which can facilitate high mass transport to a catalyst layer composed of an ultra-low loading of catalyst (1-15 μgPt cmgeo-2) at the gas/electrolyte interface. In this paper, the aspects which have critical effects on the performance of the FE system are measured and parameterised. We find that in order to obtain reproducible results with high performance the following factors need to be taken into account: system cleanliness, break-in procedure, hydrophobic agent, ionomer type and the measurements of catalyst surface area and loading. For some of these parameters, we examined a range of different approaches/materials and determined the optimum configuration. We find that the gas permeability of the hydrophobic agent is an important factor for improving the hydrogen oxidation reaction (HOR) and oxygen reduction reaction (ORR) performance. We provide evidence that the suppression of the HOR and ORR introduced by the Nafion ionomers is more than a local mass transport barrier but that a mechanism involving the adsorption of the sulfonate on Pt also plays a significant role. The work provides intriguing insights into how to manufacture and optimize electrocatalyst systems which must function at the gas/electrolyte interface.
- 25 September 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (42) , 47397-47407
Controllable Heteroatom Doping Effects of CrxCo2–xP Nanoparticles: a Robust Electrocatalyst for Overall Water Splitting in Alkaline Solutions
The effect of doping Cr on the electrocatalytic activity of supported Co2P for the hydrogen evolution reaction (HER) and oxygen evolution reaction (OER) in alkaline solution was investigated. A beneficial improvement in the performance of Co2P supported on carbon black (CrxCo2-xP/CB) towards HER and OER was discovered. For the HER at -200 mV overpotential the turnover frequency (TOF) increases almost six-fold from 0.26 to 1.52 electrons siteCo-1 s-1 when Co2P/CB has a small amount of Cr added to form Cr0.2Co1.8P/CB. Similarly, we estimate an increase from 0.205 to 0.585 electrons siteCo-1 s-1 for the OER at 1.6V for the same change in composition. With 10at% Cr doping, the Cr0.2Co1.8P/CB catalyst needed 226 mV overpotential to produce a cathodic current density of -100 A g_Co^(-1) and 380 mV overpotential to produce an anodic current density of 100 A g_Co^(-1). Based on both experimental results and theoretical calculations, the activity improvement results from optimization of electronic properties of Co2P after Cr doping.
- 25 September 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (42) , 47397-47407
Controllable Heteroatom Doping Effects of CrxCo2–xP Nanoparticles: a Robust Electrocatalyst for Overall Water Splitting in Alkaline Solutions
The effect of doping Cr on the electrocatalytic activity of supported Co2P for the hydrogen evolution reaction (HER) and oxygen evolution reaction (OER) in alkaline solution was investigated. A beneficial improvement in the performance of Co2P supported on carbon black (CrxCo2-xP/CB) towards HER and OER was discovered. For the HER at -200 mV overpotential the turnover frequency (TOF) increases almost six-fold from 0.26 to 1.52 electrons siteCo-1 s-1 when Co2P/CB has a small amount of Cr added to form Cr0.2Co1.8P/CB. Similarly, we estimate an increase from 0.205 to 0.585 electrons siteCo-1 s-1 for the OER at 1.6V for the same change in composition. With 10at% Cr doping, the Cr0.2Co1.8P/CB catalyst needed 226 mV overpotential to produce a cathodic current density of -100 A g_Co^(-1) and 380 mV overpotential to produce an anodic current density of 100 A g_Co^(-1). Based on both experimental results and theoretical calculations, the activity improvement results from optimization of electronic properties of Co2P after Cr doping.
- 4 July 2019
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 22 (9) , 1619-1629
The associations of TNF‐α gene polymorphisms with bone mineral density and risk of osteoporosis: A meta‐analysis
Objective Fracture is a common consequence of osteoporosis and is associated with high morbidity and mortality. Recently, increasing evidence has suggested that polymorphisms in tumor necrosis factor‐α (TNF‐α) gene were associated with osteoporosis risk and bone mineral density (BMD), but results remain conflicting. We herein performed a meta‐analysis based on evidence currently available from the literature to make a more precise estimation of these relationships. Methods The PubMed, EMBASE, Cochrane Library, CNKI (China National Knowledge Infrastructure) and Wan Fang databases were searched for eligible studies. Articles meeting the inclusion criteria were comprehensively reviewed and all available data were accumulated. The pooled odds ratios (ORs) or mean differences (MDs) and corresponding 95% confidence intervals (CIs) were applied to assess the strength of the relationships. Results A total of 15 studies involving 5273 subjects were included in our meta‐analysis. The GG genotype of TNF‐α G308A was associated with an increased risk of osteoporosis under a mutant model (GG vs GA+AA: OR = 0.63, 95% CI: 0.51‐0.77, P < 0.0001, I2 = 31%). Additionally, we also observed a significant association between G308A polymorphism and BMD of lumbar spine (AA vs GG: P = 0.01, I2 = 53%). However, TNF‐α T1031C, C857T and C863A polymorphisms had no obvious impacts on osteoporosis risk. Conclusions The present meta‐analysis demonstrated that TNF‐α G308A polymorphism may act as a potential candidate biomarker for screening, diagnosis, and treatment of osteoporosis, which will help improve individualized therapy of osteoporosis patients in clinics.
- 4 July 2019
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 22 (9) , 1619-1629
The associations of TNF‐α gene polymorphisms with bone mineral density and risk of osteoporosis: A meta‐analysis
Objective Fracture is a common consequence of osteoporosis and is associated with high morbidity and mortality. Recently, increasing evidence has suggested that polymorphisms in tumor necrosis factor‐α (TNF‐α) gene were associated with osteoporosis risk and bone mineral density (BMD), but results remain conflicting. We herein performed a meta‐analysis based on evidence currently available from the literature to make a more precise estimation of these relationships. Methods The PubMed, EMBASE, Cochrane Library, CNKI (China National Knowledge Infrastructure) and Wan Fang databases were searched for eligible studies. Articles meeting the inclusion criteria were comprehensively reviewed and all available data were accumulated. The pooled odds ratios (ORs) or mean differences (MDs) and corresponding 95% confidence intervals (CIs) were applied to assess the strength of the relationships. Results A total of 15 studies involving 5273 subjects were included in our meta‐analysis. The GG genotype of TNF‐α G308A was associated with an increased risk of osteoporosis under a mutant model (GG vs GA+AA: OR = 0.63, 95% CI: 0.51‐0.77, P < 0.0001, I2 = 31%). Additionally, we also observed a significant association between G308A polymorphism and BMD of lumbar spine (AA vs GG: P = 0.01, I2 = 53%). However, TNF‐α T1031C, C857T and C863A polymorphisms had no obvious impacts on osteoporosis risk. Conclusions The present meta‐analysis demonstrated that TNF‐α G308A polymorphism may act as a potential candidate biomarker for screening, diagnosis, and treatment of osteoporosis, which will help improve individualized therapy of osteoporosis patients in clinics.
- Open Access
- 1 April 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (15) , e0409
Cardioprotective effect of histamine H2 antagonists in congestive heart failure
Histamine H2 antagonists (H2RAs) have long been suggested to have beneficial effects on congestive heart failure (CHF). However, full agreement about the cardioprotective effects of H2RAs is still not reached yet. Therefore, this study aims to clarify the effects of H2RAs on myocardial function in CHF patients by meta-analysis. Electronic databases including PubMed, Embase, and Cochrane Library were retrieved. Randomized controlled trials comparing the cardiac effects of H2RAs and placebo or other medicines were collected. Pooled mean differences (MDs) with 95% confidence intervals (CIs) were calculated and meta-analysis was performed using RevMan 5.3 software. A total of 10 studies (472 participants) were included in this meta-analysis. H2RAs exhibited significant negative inotropic and chronotropic effects to reduce heart rate (MD: –3.90; 95%CI: –7.07 to –0.73, P = .02). Furthermore, although H2RAs did not affect the blood pressure in health volunteers, they significantly decreased the blood pressure of CHF patients. Additionally, H2RAs were also associated with significant increase in pre-ejection period and the ratio of pre-ejection period to left ventricular ejection time. In summary, these findings showed that H2RAs exerted negative inotropic and chronotropic effects to reduce heart rate and blood pressure, which, similar to beta-adrenergic receptor blockers, might decrease myocardial oxygen demand and eventually result in improvement of CHF symptoms. These data provided further evidence for the effect of H2RAs on cardiac function and novel potential strategy for treatment of CHF.
- 1 April 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (15) , e0409
Open AccessCardioprotective effect of histamine H2 antagonists in congestive heart failure
Histamine H2 antagonists (H2RAs) have long been suggested to have beneficial effects on congestive heart failure (CHF). However, full agreement about the cardioprotective effects of H2RAs is still not reached yet. Therefore, this study aims to clarify the effects of H2RAs on myocardial function in CHF patients by meta-analysis. Electronic databases including PubMed, Embase, and Cochrane Library were retrieved. Randomized controlled trials comparing the cardiac effects of H2RAs and placebo or other medicines were collected. Pooled mean differences (MDs) with 95% confidence intervals (CIs) were calculated and meta-analysis was performed using RevMan 5.3 software. A total of 10 studies (472 participants) were included in this meta-analysis. H2RAs exhibited significant negative inotropic and chronotropic effects to reduce heart rate (MD: –3.90; 95%CI: –7.07 to –0.73, P = .02). Furthermore, although H2RAs did not affect the blood pressure in health volunteers, they significantly decreased the blood pressure of CHF patients. Additionally, H2RAs were also associated with significant increase in pre-ejection period and the ratio of pre-ejection period to left ventricular ejection time. In summary, these findings showed that H2RAs exerted negative inotropic and chronotropic effects to reduce heart rate and blood pressure, which, similar to beta-adrenergic receptor blockers, might decrease myocardial oxygen demand and eventually result in improvement of CHF symptoms. These data provided further evidence for the effect of H2RAs on cardiac function and novel potential strategy for treatment of CHF.